It has been more than 70 years since vitamin A was first reported to play a role in the treatment of measles. The addition of vitamin A to the treatment of other common childhood illnesses remains controversial, with differing guidelines. This review analyzes the strength of the evidence for the role of vitamin A in six common childhood illnesses. We found no published papers on the use of vitamin A in chickenpox or malaria. There is strong published evidence for the use of adjuvant vitamin A in children requiring hospital admission for measles and some evidence for its use in acute shigellosis. The available evidence does not support a role for adjuvant vitamin A in acute lower respiratory tract infections or acute watery diarrhea. There is insufficient evidence on the role of vitamin A in the treatment of persistent diarrhea, acute measles not requiring admission, and protein-energy malnutrition to guide policy
Introduction
Population-based studies have shown that vitamin A supplementation can reduce childhood mortality rates in considerably vitamin A-deficient communities [1] [2] [3] [4] . Vitamin A was first reported to play a possible role in reducing the mortality from complications of measles nearly 70 years ago [5] . The current Integrated Management of Childhood Illness guidelines recommend the use of vitamin A in children presenting to health-care workers with measles or severe proteinenergy malnutrition [6] . However, other guidelines from the World Health Organization (WHO) have also suggested adjuvant treatment with high-dose vitamin A in children presenting to health care workers with diarrhea, respiratory disease, or chicken pox [7] . The purpose of this review is to analyze the strength of the evidence for the role of vitamin A in acute childhood illness.
Methods
The medical literature databases Medline, Popline, and Embase were searched for published articles on the use of vitamin A in the treatment of the following six childhood illnesses: diarrhea (acute, persistent, and dysentery), acute lower respiratory tract infections, measles, malaria, chickenpox, and severe proteinenergy malnutrition.
Searches were performed using the above terms and for all years available for each database. For Medline this was from 1966, for Popline from 1970, and Embase from 1988 to date. The abstracts for each of the identified studies were read by one of the authors (LMN), and articles relevant to the present review were noted. These papers were then read in full, and those reporting original studies examining the role of vitamin A in the treatment of the six childhood illnesses were included. The bibliographies of review articles were also searched for additional papers not found on preliminary literature review.
We included only original papers reporting randomized clinical trials of adjuvant treatment with vitamin A in children with acute illness [8] . Three studies did not fit into this category but are still included in this review [9] [10] [11] . One paper from Cape Town (South Africa) reported on a retrospective record review of children under 15 years old admitted to the hospital with measles [9] . The authors analyzed the morbidity and mortality data for children admitted over two nonconsecutive time periods before and after the introduction of routine high-dose vitamin A in the acute treatment of measles at their hospital. The authors had already published the results of a randomized clinical trial that is also included here [12] and performed the retrospective analysis to evaluate the efficacy and tolerance of high-dose vitamin A in routine clinical use.
In order to evaluate the tolerance of high-dose vitamin A in children, two randomized, placebocontrolled community trials are included in the review [10, 11] . Both of these papers stated that their primary aim was to evaluate the tolerance of vitamin A in children and are included here because the larger study populations ensure a greater power to detect rare side effects.
The other studies that are included are doubleblind, randomized clinical trials, including two that were published as letters [13, 14] . However, there has been no standard dose or type of vitamin A used; the studies include different ages and inclusion criteria, and outcome measures are not standardized. This makes an overall statistical analysis of the evidence difficult, and we have therefore chosen to summarize the results of the studies as tables. The discussion summarizes the available data and focuses on further research required. Table 1 illustrates the number of studies identified by each of the databases and the number of studies included in this review. The number of articles available on each of the subjects is not equally distributed. We found no publications on the use of adjuvant vitamin A in acute malaria, and there was only one published letter on the role of vitamin A in chickenpox. We identified 6 articles on diarrhea, 12 on acute lower respiratory tract infections, 8 on measles, and 1 on severe protein-energy malnutrition. The authors of one of the papers included in all three of these sections [15] conducted a randomized clinical trial of the use of vitamin A in children presenting to their hospital in the Democratic Republic of the Congo. The majority of the children in this study had severe protein-energy malnutrition, and outcome measures included the morbidity from diarrhea or respiratory tract infections. The results are summarized in tables 2 to 7.
Results

Conclusions Diarrhea
Six published articles of trials of vitamin A in children with diarrhea were found (table 2) . Four evaluated the role of vitamin A in children with acute watery diarrhea, one in children with acute shigellosis, and one diarrhea in malnourished children. A study from Dhaka, Bangladesh, used a randomized, controlled trial with factorial design to compare the use of vitamin A, zinc, or both with a placebo in children with diarrhea of less than three days' duration [19] . The authors used logistic regression analysis to reduce confounding variables. Children were given 4,500 IU of vitamin A per day for 15 days, and no reduction in the mean duration of diarrhea was observed. There was, however, a trend towards a reduction in the risk of prolonged diarrhea (>7 days) in this group, but it was not significant (p = .09).
Another study from New Delhi, India, evaluated the role of vitamin A supplementation in children between the ages of six months and five years presenting with acute diarrhea of less than three days' duration [17] . The authors used the standard WHO dose of vitamin A of 200,000 IU (100,000 IU for infants and children weighing less than 10 kg or younger than one year) but again found no reduction in the mean duration of diarrhea. However, on subgroup analysis, children who had preexisting vitamin A deficiency (defined as conjunctival impression cytology stage 3/5 or above) had a significant reduction in the duration of diarrhea. Henning et al., in another study from Bangladesh, also failed to find a decrease in the duration of acute watery diarrhea in children supplemented with 200,000 IU of vitamin A [16] , as did a Turkish study using 100,000 IU of vitamin A in children 6 to 12 months old [20] . In contrast, Hossain et al. gave 200,000 IU of vitamin A to children with acute shigellosis in Bangladesh and reported an increase in the proportion of children who were clinically cured at five days in the supplemented group [18] .
A study from the Democratic Republic of the Congo failed to find a reduction in diarrhea among malnourished children given 200,000 IU of vitamin A [15] . However, when severely malnourished children were given a low-dose regimen of 5,000 IU of vitamin A each day during their admission, there was a significant reduction in the incidence, but not the duration, of severe diarrhea.
Donnen et al. reported that children with no edema who were given the high-dose vitamin A had an increased risk of severe nosocomial diarrhea (RR = 2.42; 95% CI, 1.15-5.11) [15] . In the other four studies, there were no reported adverse effects from vitamin A.
The addition of zinc to the treatment regimen does appear, however, to significantly reduce the mean duration of the diarrhea and the risk of prolonged diarrhea. A subgroup analysis of zinc use in stunted children was associated with a 19.3% reduced risk of diarrhea [19] .
Acute lower respiratory tract infections
Twelve published papers were found evaluating the role of adjuvant therapy with vitamin A in children with acute lower respiratory tract infections. Four studies examined the role of high-dose vitamin A in children with laboratory-confirmed respiratory syncytial virus (RSV) disease (table 3) . Three of these were from the United States (including one multicenter trial) [14, 21, 22] and one from Santiago, Chile [23] . In all three papers from the United States, children given high-dose vitamin A had longer lengths of stay than children given a placebo. This difference was statistically significant only in the paper by Bresee et al., which had the largest study numbers [21] . They suggested that their results were due to subtle vitamin A toxicity. The differences in length of stay were most significant in those children at low risk of severe RSV disease and those over 12 months of age. Older children with RSV disease generally have a milder illness than young children, and in combination with much higher doses of vitamin A in this age group, this may explain the adverse effects of vitamin A in this age group [21] .
The study from Santiago, Chile, showed no overall benefit from vitamin A in children hospitalized for RSV infection. However, vitamin A recipients were less likely to receive oxygen, bronchodilators, and steroids after enrollment and spent fewer days in the hospital. However, none of these differences were statistically significant. For the subgroup of children with significant hypoxemia on admission (room air oxygen saturation level < 90%), those given vitamin A had a more rapid resolution of tachypnea (p = .01) and a shorter duration of hospitalization (p = .09) [23] . Children in Santiago are well nourished, and xerophthalmia and clinical vitamin A deficiency are not known to occur. In addition, baseline vitamin A levels were not lower in the Chilean study than in the US studies. The authors suggest that the younger age of the children in the Chilean study may be important, since the prolongation of hospital stay in the US multicenter trial was seen in those subjects older than 12 months of age. The authors concluded that if vitamin A is effective for the treatment of RSV, the effect is small and may only be seen in subgroups of children with severe disease [23] .
Neuzil et al., in a letter to the Pediatric Infectious Diseases Journal, reported on results from a trial in Nashville, Tenn., USA [14] . After an initial safety trial, they began a randomized controlled trial of 50,000 IU of vitamin A on two consecutive days in children under 12 months old admitted to their hospital with RSV. Early in their study, a seven-week-old child with a mild respiratory illness developed a bulging fontanelle and an associated vitamin A level of 115 µg/dl six hours after receiving the first 50,000 IU of vitamin A. The second dose was not administered. By 24 hours, the serum vitamin A concentration had returned to normal, and by 48 hours, the fontanelle was flat. At this point they reduced their vitamin A dosage to 25,000 IU on two consecutive days. The first child to receive this new dose (three months of age) also developed a bulging fontanelle and a serum vitamin A concentration of 95 µg/dl six hours after the dose was given. Again the level returned to normal within 24 hours, and the fontanelle had flattened by 48 hours. All 22 subsequently enrolled children were given two consecutive doses of 12,500 IU of vitamin A without further evidence of toxicity. The children who received vitamin A in this study also had a higher mean length of stay, although this was not statistically significant, possibly because of small sample sizes [14] .
Nonspecifi c acute lower respiratory tract infections
Kjolhede et al. gave 200,000 IU of vitamin A to children admitted to a hospital in Guatemala City with radiographically confirmed acute lower respiratory tract infections and found almost identical mean respiratory rates and temperatures in those children treated and not treated with adjuvant vitamin A [24] (table 4 ). The authors commented that their study population was relatively replete compared with populations used for the vitamin A mortality trials, and thus the subjects might not be expected to respond to vitamin A. They suggested repeating similar trials in areas where vitamin A deficiency is more prevalent and severe [24] . Three other studies used the higher dose of 400,000 IU of vitamin A in children with lower respiratory tract infections and found no decrease in days to resolution of fever, resolution of tachypnea, hospital stay, or response to first-line antibiotic [25] [26] [27] . However, on subgroup analysis, Nacul et al. found that Brazilian children not receiving vitamin A required a change of their first-line antibiotic earlier [25] .
Donnen et al., in their study of malnourished children from the Democratic Republic of the Congo, found no effect of vitamin A on the length of an episode of lower respiratory tract infection, either for a single dose of 200,000 IU or for the low-dose regimen of 4,500 IU daily [15] . Fawzi et al. also found no effect of vitamin A in Tanzanian children, even those in the lowest decile of dietary intake [27] .
There is some evidence that the use of vitamin A supplementation in the treatment of pneumonia could have adverse effects. Stephensen radiographically confirmed pneumonia [28] . The children given vitamin A had a longer duration of clinical signs and a greater need for supplemental oxygen. These adverse effects were not so severe as to require longer hospitalization, produce untoward clinical outcomes, or produce significant differences in chest X-ray findings at the follow-up examination, but they did result in more nursing time and higher costs of care. There was a tendency toward a longer duration to normalization of respiratory rate in Vietnamese children without malnutrition [26] . However, a paper from Mozambique published after the initial review was presented to WHO reported a significant difference in the percentage of children discharged before day five among those given 200,000 IU of vitamin A on admission for acute lower respiratory tract infections. This difference was particularly important in children less than one year of age. They found no significant difference in this criterion between the two groups at six weeks of follow-up. They concluded that it is likely that response to vitamin A is only significant in societies with low mean vitamin A levels such as theirs, and that although there was no significant clinical difference at six weeks, a reduction in hospital stay would have important financial implications [29] .
Large doses of vitamin A may be beneficial in some children with underlying hypovitaminosis, but there is no evidence that it should be used in all children, since there is a high rate of adverse effects in children hospitalized for acute lower respiratory tract infections.
Measles
The evidence for a role of adjuvant vitamin A in the treatment of measles is strong, and its use has become standard practice. There are, however, differences in the dose recommended by WHO and the dose used in the initial trials. Barclay et al. and Hussey et al., in two separate randomized, clinically controlled trials, gave 200,000 IU of vitamin A on two consecutive days to children admitted to the hospital for acute measles [12, 30] (table 4) . Both studies showed significant reductions in measles-associated morbidity and mortality. In the study from Tanzania, there was a reduction in mortality from measles from 13% in the treatment group to 7% in the control group, although this was not significant. The largest decrease in mortality was seen in the under two-year-old children and in those children who had measles-related complications, especially croup [30] . Hussey and Klein followed up this randomized, controlled trial by showing in a retrospective records review that the introduction of vitamin A regimen in their hospital had led to significant reductions in mean stay, admission to the intensive care unit, and death from measles in children under 15 years old [9] .
Another study from South Africa used the WHOrecommended dose of vitamin A in 60 children admitted to the hospital for measles complicated by pneumonia or diarrhea. There was a significant improvement in recovery and in the children's integrated morbidity scores [31] .
Rosales et al. studied the effect of a WHO dose of vitamin A on the outcome of acute measles in 200 Zambian children not requiring hospital admission [33] . There was no difference in measles complications during the acute stage of the illness. On cross-sectional analysis at four weeks, there was a significant reduction in cough and pneumonia in the vitamin A group, but when longitudinal analyses were performed, there was no statistically significant benefit from the use of vitamin A.
No adverse effects were found in children with measles treated with high-dose vitamin A, probably because these children had low serum levels of the vitamin.
Chickenpox
In a letter to the Journal of Pediatrics, Özsoylu et al. published results of a clinical controlled trial of the use of vitamin A in chickenpox [13] (table 5) . They gave 200,000 IU of vitamin A to 47 children with acute chickenpox and none to 46 controls. Crusting of the lesions occurred significantly earlier in the study group (5.34 as opposed to 6.37 days, p < .01). They concluded that vitamin A should be given to all children with acute chickenpox on the first day of the eruption. However, the confidence intervals were very wide (95% CI, 3.82-6.86 days in treated children and 5.03-7.71 days in the untreated), and we are therefore unsure as to the statistical validity of their conclusions. We found no other studies evaluating the role of vitamin A in chickenpox.
Severe protein-energy malnutrition
The only published trial on the use of vitamin A in malnourished children was from the Democratic Republic of the Congo [15] (table 6) . However, the inclusion criteria stated only that the children were admitted to the Lwiro Pediatric Hospital. Although most children admitted to the hospital are malnourished, not all of them are. The study evaluated the effect of vitamin A given in two different doses on mortality from, duration of, and incidence of acute lower respiratory tract infection or diarrhea and allcause fevers. Neither vitamin A regimen had an effect on the case fatality rates, median length of stay, or incidence of all-cause fevers. As mentioned previously, in children with severe protein-energy malnutrition, a daily dose of 5,000 IU significantly reduced the incidence, but not the duration, of severe diarrhea. 
Safety and tolerance
Children between one and six months of age given 100,000 IU of vitamin A in a community study in Nepal had a 1.6% excess risk of vomiting (statistically significant) and a 0.5% excess risk of bulging fontanelles (not significant) (table 7) . There was no increased risk of vomiting or a bulging fontanelle in infants under one month old. There was no increased risk of irritability or fever in either group [10] . Infants in this study were examined only at 24 hours. It is possible that if they had been examined earlier, the side effects might have been greater [11] . Older children aged one to six years given 200,000 IU of vitamin A in the Philippines complained of nausea, vomiting, and headache four times more often than children given placebo [9] . The effect was dose related, since children given 200,000 IU complained twice as much of symptoms as children given 100,000 IU of vitamin A [10] .
Policy conclusions regarding effi cacy
The evidence for a beneficial effect of large-dose vitamin A in acute pediatric illness has been reviewed in published reports. There is: » Strong evidence that high-dose vitamin A is beneficial in the treatment of complicated measles requiring hospital admission; » Some evidence that high-dose vitamin A is beneficial in the treatment of acute shigellosis; » Evidence that high-dose vitamin A is not beneficial in the treatment of acute watery diarrhea or acute lower respiratory tract infections; » Insufficient evidence on the role of high-dose vitamin A in the treatment of persistent diarrhea, acute measles not requiring hospital admission, and protein-energy malnutrition; » No published information on the use of vitamin A in the treatment of chickenpox or acute malaria. 
Policy conclusions regarding safety
